The presence of PFAS in the environment requires governmental agencies to establish regulatory limits for PFAS in human essentials, such as drinking water. LC–MS/MS can be used to analyze a wide range of sample types containing PFAS, but avoiding PFAS contamination is critical for this technique to work effectively.
Analytical methods are developed at various stages of the drug develoment process for samples of varying complexity.
This article aims to demonstrate a novel accelerated method development approach to develop HPLC and/or UPLC methods